EXELON PATCH 15 13.3 MG / 24 HOUR
RIVASTIGMINE : 13.3 MG / 24 HOUR · DIN 02432803 · KNIGHT THERAPEUTICS INC.
Health Canada status: MARKETED
What is EXELON PATCH 15?
EXELON PATCH 15 13.3 MG / 24 HOUR contains RIVASTIGMINE : 13.3 MG / 24 HOUR. It is listed in the Health Canada Drug Product Database under DIN 02432803, held by KNIGHT THERAPEUTICS INC., supplied as PATCH for TRANSDERMAL administration. Health Canada currently lists it as marketed, status dated 26-Oct-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EXELON PATCH 15 used for?
EXELON® PATCH (rivastigmine transdermal patch) is indicated for the symptomatic treatment of patients with mild to moderately severe dementia of the Alzheimer's type. EXELON® PATCH has not been studied in controlled clinical trials for longer than 6 months. EXELON® PATCH should only be prescribed by (or following consultation with) clinicians who are experienced in the diagnosis and management of Alzheimer’s disease.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02432803 |
|---|---|
| Brand name | EXELON PATCH 15 |
| Generic / active ingredient | RIVASTIGMINE : 13.3 MG / 24 HOUR |
| Manufacturer | KNIGHT THERAPEUTICS INC. |
| Strength | 13.3 MG / 24 HOUR |
| Dosage form | PATCH |
| Route of administration | TRANSDERMAL |
| Schedule | Prescription |
| ATC code | N06DA03 RIVASTIGMINE |
| AHFS class | 12:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Oct-2022 |
| Original market date | 2015-04-17 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Available in cartons of 30.
What can be used instead?
Other Canadian products sharing ATC code N06DA03 RIVASTIGMINE. 28 of 80 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 1.5 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02336715 |
| APO-RIVASTIGMINE | 3 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02336723 |
| APO-RIVASTIGMINE | 4.5 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02336731 |
| APO-RIVASTIGMINE | 6 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02336758 |
| EXELON | 1.5 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02242115 |
| EXELON | 2 MG | SOLUTION | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02245240 |
| EXELON | 3 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02242116 |
| EXELON | 4.5 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02242117 |
| EXELON | 6 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02242118 |
| EXELON PATCH 10 | 9.5 MG / 24 HOUR | PATCH | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02302853 |
Who else supplies RIVASTIGMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. RIVASTIGMINE appears in 242 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.